Carevive Blog


Applying a Shared Decision-Making Framework for Treatment Planning in DLBCL and FL

Release date: May 22, 2019 
Expiration date: May 21, 2020 Physicians – Maximum of 1.0 AMA PRA Category 1 Credits™ Registered Nurses – 1.0 contact hours (0.7 pharmacotherapy) Target Audience The target audience for this activity is U.S.-based hematologists/oncologists, advanced practice nurses, physician assistants, oncology nurses, nurse navigators, and cancer center administrators caring for patients with non-Hodgkin lymphoma. Educational Objectives After completing…
May 22, 2019

Evolving Evidence-Based Treatment Paradigms for Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)

Release date: April 15, 2019 
Expiration date: April 14, 2020 Estimated time to complete activity: 45 minutes In 2018, there will be an estimated 164,690 new cases of prostate cancer (PC) in the U.S. and approximately 29,430 patients will die of the disease, making it the third-leading cause of cancer death in men (American Cancer Society , 2018). The majority…
April 15, 2019
Press Releases

Ethan Basch to Lead Carevive’s Scientific Advisory Board

Patient-reported outcomes research pioneer, Ethan Basch, MD, MSc, FASCO will serve as Scientific Advisory Board Director to build health care technology company’s patient-reported outcomes (PRO) and RWE analytics platform. North Miami, Florida — February 26, 2019 — Carevive, a health technology company that builds cancer care management and patient engagement solutions to improve patient quality of life and clinical outcomes, announced…
February 26, 2019
In The News

Improving End-of-Life Care for Cancer Patients – An Advisory Board Company Profile on Carevive

Advisory Board Company includes Carevive in a report detailing four tactics to improve quality and patient experience while reducing costs As published in The Advisory Board Company website. Improving care at the end-of-ife is a prime opportunity for cancer programs to drive quality, decrease costs, and enhance the patient and family experience. Aggressive end-of-life care that provides no clinical benefit,…
February 15, 2019
EventsIn The News

Carevive announces webinar focusing on electronic patient-reported outcomes (ePROs)

Carevive will be hosting a webinar titled Demystifying implementation of ePROs in oncology clinical care on January 16th, 1 PM EST.  Speakers will include Ethan Basch, MD, MSc, Diane Baldwin RN, OCN, CBCN, and other Carevive presenters. Integrating patient-reported outcomes (PROs) into clinical practice is an increasingly promising strategy for improving patient engagement, symptom control, and clinical outcomes, including reducing avoidable hospitalizations and…
December 19, 2018

Carevive Will Be Presenting at 2018 Palliative and Supportive Care In Oncology Symposium

The Carevive team will be attending and presenting a poster at the Palliative and Supportive Care in Oncology Symposium in San Diego. Come to Board B2 to learn more and discuss with Carevive the details and outcomes of this study critical to the ongoing management of cancer patients who have pain. Poster Session A: Communication and Shared Decision Making; Integration and Delivery…
November 12, 2018
In The News

Strengthening Bonds in Cancer Care

A startup founded by Penn Nursing grads uses data to improve care management. Originally posted in Penn Nursing. Carevive, a cancer care management and patient engagement platform that provides patients, cancer care teams, and life sciences companies with access to data and insights to improve the quality of care, was founded in 2013 by Penn Nursing graduates Carrie Tompkins Stricker…
October 24, 2018

What’s New in Acute Myelogenous Leukemia?

Release date: October 17, 2018 
Expiration date: October 16, 2019 Estimated time to complete activity: 0.75 hours Acute myelogenous leukemia (AML) is a disease of older adults, with a median age of presentation of 67 years; only 5-10% of patients are alive at 5 years. Traditionally older patients have not received intensive induction chemotherapy to avoid toxicities, yet current research shows fit…
October 17, 2018